Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05095168
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Ascending Dose (SAD) of CAN106 Administered Intravenously (IV) in Healthy Subjects

Who this might be right for
PNH
CARE Pharma Shanghai Ltd. 31
Early research (Phase 1)Looking for participantsNCT06559618
What this trial is testing

Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria

Who this might be right for
BacteriuriaSpinal Cord InjuriesAsymptomatic Bacteriuria+1 more
Barbara Trautner 30
Early research (Phase 1)Looking for participantsNCT07568678
What this trial is testing

A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hua Medicine Limited 40
Testing effectiveness (Phase 2)Study completedNCT05124925
What this trial is testing

Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.

Who this might be right for
Sjogren Syndrome
Novartis Pharmaceuticals 21
Early research (Phase 1)Study completedNCT06945458
What this trial is testing

Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Kymera Therapeutics, Inc. 22
Early research (Phase 1)Study completedNCT04848558
What this trial is testing

Nipocalimab in Healthy Male and Female Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 89
Early research (Phase 1)Study completedNCT02956850
What this trial is testing

A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 160
Early research (Phase 1)Study completedNCT01721980
What this trial is testing

Multiple Ascending Dose Study of GLPG0974 in Healthy Subjects

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 32
Early research (Phase 1)Study completedNCT01889160
What this trial is testing

Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose Levels

Who this might be right for
Safety,Plasma AUC and Cmax, Plasma AUC 0-t, t1/2λz, and Tmax
AstraZeneca 44
Early research (Phase 1)Study completedNCT00563524
What this trial is testing

Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis

Who this might be right for
Psoriasis
Wyeth is now a wholly owned subsidiary of Pfizer 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07773246
What this trial is testing

Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD

Who this might be right for
Urea Cycle Disorders, InbornUrea Cycle DisordersOrnithine Transcarbamylase (OTC) Deficiency+8 more
Korro Bio, Inc. 30
Early research (Phase 1)Study completedNCT03238027
What this trial is testing

Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors

Who this might be right for
Solid TumorMetastatic TumorLocally Advanced Malignant Neoplasm+1 more
Syndax Pharmaceuticals 45
Early research (Phase 1)Ended earlyNCT02439346
What this trial is testing

Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel

Who this might be right for
Medical Oncology
Bayer 15
Early research (Phase 1)Study completedNCT02834442
What this trial is testing

Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects

Who this might be right for
Healthy
Tanabe Pharma Corporation 144
Early research (Phase 1)Not Yet RecruitingNCT07736586
What this trial is testing

HL40626S Tablets in Healthy Adults

Who this might be right for
Psoriasis (PsO)Skin DiseaseImmune System Disease+1 more
HighsLab Therapeutics Inc. 64
Early research (Phase 1)Study completedNCT00682097
What this trial is testing

A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 55
Early research (Phase 1)Study completedNCT04588727
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects

Who this might be right for
Cardiovascular Disease
AstraZeneca 103
Early research (Phase 1)Not Yet RecruitingNCT07628582
What this trial is testing

The LVIVO-TaVec122 Product in Subjects With Relapsed/Refractory B-cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell Malignancies
The First Affiliated Hospital with Nanjing Medical University 48
Early research (Phase 1)Study completedNCT04169386
What this trial is testing

PCSK9 Inhibitor AK102 in Healthy Subjects

Who this might be right for
Hypercholesterolaemia
Akeso 32
Early research (Phase 1)Study completedNCT06487845
What this trial is testing

Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants

Who this might be right for
Chronic Kidney DiseaseNon-proliferative Diabetic RetinopathyHealthy Volunteers
Bayer 24
Next Page